Peptron

087010.KQ

64.98 USD

-2.49

-3.69%

Overview

Last close

64.98 usd

Market cap

995.93M usd

52 week high

93.90 usd

52 week low

12.43 usd

Target price

24.23 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

803.5906

Price/Book Value

105.508

Enterprise Value

1.52B usd

EV/Revenue

910.9425

EV/EBITDA

-17.5233

Key financials

Revenue TTM

4.02M usd

Gross Profit TTM

3.09M usd

EBITDA TTM

-7.43M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

41.87B usd

Net debt

N/A usd

About

Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.